LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer

Background: Breast cancer (BRCA) represents the most frequent diagnosed malignancy in women worldwide. Despite treatment advances, BRCAs eventually develop resistance to targeted therapies, resulting in poor prognosis. The identification of new biomarkers, like immune-related long non-coding RNAs (l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca-Montaño, Marco Antonio, Cisneros-Villanueva, Mireya, Coales, Isabelle, Hidalgo-Miranda, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228735/
https://www.ncbi.nlm.nih.gov/pubmed/37260772
http://dx.doi.org/10.3389/fgene.2023.1034569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228735/
https://www.ncbi.nlm.nih.gov/pubmed/37260772
http://dx.doi.org/10.3389/fgene.2023.1034569

Ejemplares similares